http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2193367-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
filingDate 1995-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63e23605bb3ba245d4587d62aa74d3ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b1dcb2e44eed69d2c8546c8ca638ae
publicationDate 1996-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2193367-A1
titleOfInvention (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
abstract This invention relates to novel 4-(3,4-dioxocyclobuten-1-yl)chromenes and dihydronaphthalenones and 3-(3,4-dioxocyclobuten-1-yl)indenes and salts thereof having smooth muscle relaxing activity, to their use in the treatment of hypertension as well as for treatment of peripheral vascular disease, congestive heart failure, disorders involving excessive smooth muscle contraction of the urinary tract such as incontinence or of the gastrointestinal tract such as irritable bowel syndrome, asthma, and hair loss and to pharmaceutical compositions containing an invention compound. The present invention discloses compounds represented by formula (I), wherein R1 and R2, independent from each other, are selected from the following: C1-6 perfluoroalkoxy, C1-6 perfluoroalkyl, C1-6 alkyl, C1-6 alkoxy, hydroxyl, C1-6 alkoxycarbonyl, nitro, cyano, halogen, C1-6 alkylsulfonamido, C1-6 perfluoroalkylsulfonamido, amino, C1-6 acylamino, C1-6 perfluoroacylamino, mono or di-C 1-12 alkylamino, C1-6 alkylsulfonyl, C6-10 arylsulfonyl, carboxyl, C1-12 mono or di-alkylaminocarbonyl, or hydrogen; a and b together form an -O- linkage, C=O, or a direct bond; R3 and R4, independent from each other, are H or C1-6 alkyl, optionally substituted by fluorine; R5 is amino or C1-12 mono alkylamine; R6 is H, C1-6 perfluoroalkyl, C1-6 alkyl, C6-10 aryl, or mono or bicyclic heteroaryl containing 1-3 heteroatoms selected from N, O, or S.
priorityDate 1994-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410714557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15291206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15291207
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88340684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426714375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413683536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414199489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409994468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422350997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414804129
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421766155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422393632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18995791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447566140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426412537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57429993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9925679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494610
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457781088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393644

Total number of triples: 70.